Overview

S.P.PRO LIVER POWDER is Used to Improve Liver and Metabolic Indexes in People With Non-alcoholic Fatty Liver Disease

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
With the Westernization of the diet and insufficient exercise, Taiwan's population of obesity, diabetes, and hyperlipidemia has increased in recent years, and the prevalence of the non-alcoholic fatty liver disease has gradually increased. Although weight loss, dietary adjustments, and certain drug treatments can delay the deterioration of the disease; however, weight loss and dietary adjustment are not easy.
Phase:
Phase 4
Details
Lead Sponsor:
Taipei Medical University WanFang Hospital
Collaborator:
Sheng Pu Pharmaceutics Co., Ltd.